Our results indicate therefore that OM-85 treatment keeps innate immune cells in an “alerted state” ideal to release large amounts of IL-1 upon sensing an inflammasome trigger and, conceivably, to reduce selected viral infections. This evidence concerns the gene IL1B and ocular melanoma.